Products

Debatrix

Uses AI

Where Great Minds Act & Decide

debatrix.in Creator Economy & Community / Social Networks & Apps

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Anshuman Sharma
@debatrix_in· 2 followers
Launched
8mo ago
2026-03-18 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 change · 1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@debatrix_in
  • Launched on Product HuntLaunch

    Live structured debate platform

    Mar 18 · 8mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct35%
  • Organic Search33%
  • Referrals11%
  • Social6%
  • Other14%

Countries

No data yet

Search

Domain authority —Domain registered 2026-03-15

KeywordMonthly volume
debate online1,950
helle lyng1,150
debatrix480
debate websites200
free online debate platform for students160

Traffic data: Vaneform

Pricing

Website does not list public plan prices.

Trial: None · Observed 2026-11-03 · Source page

Pages & changes

Tracked since 2026-03-18

Key pages

Weekly snapshots
www.debatrix.in/ Snapshot 2026-11-03

Changes

  1. Nov 3 · 13d ago

    Homepage tagline changed to “Where Great Minds Act & Decide”Positioning

    Where Great Minds Lead & Decide→Where Great Minds Act & Decide

    At the time: <5K visits/mo

Questions & evidence

How much website traffic does Debatrix get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Debatrix and what platforms does it support?
Debatrix is catalogued under Social Networks & Apps: Where Great Minds Act & Decide. Supported platforms: Web.

Related products in this category

Creator Economy & Community / Social Networks & Apps

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.